Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.444, 2004-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Screening for proteinuria warranted in the US?
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :
Which screening test for diabetes best value in the US?
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :
Improving uptake of breast cancer screening worth it in the US?
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Improving uptake of breast cancer screening worth it in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. :
The return of Tysabri to the market in the US?
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :